Cerus (CERS) Shareholder's Equity (2010 - 2026)

Cerus (CERS) Shareholder's Equity (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 52.06 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 22.98 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 10.33 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 10.67 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.34 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 2.96 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 7.20 Bn
10 Cerus 496.03 Mn 416.34 Mn 27.89 Mn 67.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 67.55 Mn
Dec 31, 2025 64.97 Mn
Sep 30, 2025 62.20 Mn
Jun 30, 2025 56.17 Mn
Mar 31, 2025 56.24 Mn
Dec 31, 2024 56.90 Mn
Sep 30, 2024 54.28 Mn
Jun 30, 2024 50.30 Mn
Mar 31, 2024 50.16 Mn
Dec 31, 2023 53.44 Mn
Sep 30, 2023 49.02 Mn
Jun 30, 2023 51.69 Mn
Mar 31, 2023 59.56 Mn
Dec 31, 2022 68.56 Mn
Sep 30, 2022 74.07 Mn
Jun 30, 2022 76.76 Mn
Mar 31, 2022 80.41 Mn
Dec 31, 2021 85.62 Mn
Sep 30, 2021 81.08 Mn
Jun 30, 2021 84.24 Mn